BD Cheson, L Lacerna, B Leyland-Jones, G … - Annals of internal medicine, 1989 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Purpose: To assess the current status of high-dose chemotherapy with ... Cited by 119 - Related articles - All 3 versions
- ►ascopubs.org [PDF] E Frei… - Journal of Clinical Oncology, 1989 - jco.ascopubs.org Autologous bone marrow transplantation (AuBMT) is in clinical trial for patients
with metastatic solid tumors, particularly breast cancer. This review deals with
the potential of this approach. AuBMT is curative for the leukemias and ... Cited by 150 - Related articles - All 5 versions
K ANTMAN, RP GALE - Annals of internal medicine, 1988 - Am Coll Physicians The response of human breast cancer to drugs and radiation is dose-dependent,
with higher doses producing increased response rates. However, dose escalation
of several agents active against breast cancer is limited by bone marrow ... Cited by 71 - Related articles - All 3 versions
JO Armitage, RP Gale - The American journal of medicine, 1989 - ncbi.nlm.nih.gov Bone marrow autotransplantation involves the administration of very high doses
of chemotherapy or radiation therapy, or both, followed by infusion of
autologous hematopoietic stem cells. This treatment was used in the past as ... Cited by 16 - Related articles - All 2 versions
K Antman, JP Eder, A Elias, T Shea, WP … - Cancer Treat. Rep., 1987 - grande.nal.usda.gov Record Detail. Return to previous page, Save: Title: High-dose combination
alkylating agent preparative regimen with autologous bone ... Cited by 48 - Related articles - Cached - All 4 versions
- ►jcojournal.org [PDF] CR Nichols, G Tricot, SD Williams, K Van … - Journal of Clinical Oncology, 1989 - jcojournal.org THE DEVELOPMENT of cisplatin as an antineoplastic agent remains a landmark
advance in modern oncology. The drug has re- markable single-agent activity in a
broad array of tumors.' In addition, the use of this compound in ... Cited by 196 - Related articles - All 7 versions
- ►ascopubs.org [PDF] WP Peters, JP Eder, WD Henner, S Schryber, … - Journal of Clinical Oncology, 1986 - jco.ascopubs.org A LKYLATING AGENTS exhibit a steep dose response effect' and broad clinical
activity in a variety of human neoplasms. Fur- ther, in both animal and human
experimental systems, selected alkylating agents have been shown to lack ... Cited by 97 - Related articles - All 5 versions
- ►ascopubs.org [PDF] CR Nichols, J Andersen, HM Lazarus, H … - Journal of Clinical Oncology, 1992 - jco.ascopubs.org Purpose: A phase 11 trial was undertaken to assess the feasibility, toxicity,
and efficacy of high-dose carboplatin and etoposide with autologous bone marrow
transplanta- tion in patients with relapsed or refractory germ cell tumors. ... Cited by 107 - Related articles - All 7 versions
